- Home
- BANL vs ACHL Comparison
BANL vs ACHL Comparison
Compare BANL & ACHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BANL
- ACHL
- Stock Information
- Founded
- BANL 2015
- ACHL 2016
- Country
- BANL Malaysia
- ACHL United Kingdom
- Employees
- BANL N/A
- ACHL N/A
- Industry
- BANL Oil Refining/Marketing
- ACHL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BANL Energy
- ACHL Health Care
- Exchange
- BANL Nasdaq
- ACHL Nasdaq
- Market Cap
- BANL 17.6M
- ACHL 29.0M
- IPO Year
- BANL 2023
- ACHL 2021
- Fundamental
- Price
- BANL $1.05
- ACHL $1.02
- Analyst Decision
- BANL
- ACHL Hold
- Analyst Count
- BANL 0
- ACHL 3
- Target Price
- BANL N/A
- ACHL $2.83
- AVG Volume (30 Days)
- BANL 52.5K
- ACHL 1.9M
- Earning Date
- BANL 09-12-2024
- ACHL 11-11-2024
- Dividend Yield
- BANL N/A
- ACHL N/A
- EPS Growth
- BANL N/A
- ACHL N/A
- EPS
- BANL N/A
- ACHL N/A
- Revenue
- BANL $521,173,543.00
- ACHL N/A
- Revenue This Year
- BANL N/A
- ACHL N/A
- Revenue Next Year
- BANL N/A
- ACHL N/A
- P/E Ratio
- BANL N/A
- ACHL N/A
- Revenue Growth
- BANL 24.34
- ACHL N/A
- 52 Week Low
- BANL $0.55
- ACHL $0.63
- 52 Week High
- BANL $2.14
- ACHL $1.76
- Technical
- Relative Strength Index (RSI)
- BANL 69.76
- ACHL 70.08
- Support Level
- BANL $0.62
- ACHL $0.96
- Resistance Level
- BANL $0.68
- ACHL $1.08
- Average True Range (ATR)
- BANL 0.08
- ACHL 0.06
- MACD
- BANL 0.05
- ACHL 0.02
- Stochastic Oscillator
- BANL 100.00
- ACHL 84.62
About BANL CBL International Limited
CBL International Ltd is a company that provides a complete range of marine fuel logistics services. It sources the highest quality marine fuel from its trusted suppliers and ensures timely delivery to its customers. The company's expertise lies in providing a seamless and efficient one-stop solution for vessel refueling needs, making it a reliable partner for shipping companies. CBL International Ltd has a strong presence in China, Hong Kong, and Malaysia.
About ACHL Achilles Therapeutics plc
Achilles Therapeutics PLC is a biopharmaceutical company. It is developing AI-powered precision T-cell therapies targeting clonal neoantigens to treat solid tumors. The company has two ongoing trials, the CHIRON trial in patients with non-small-cell lung cancer and the THETIS trial in patients with recurrent or metastatic melanoma.